Table 2.
Pre-analytical recommendations for BRCA testing
| Sample type | Key recommendations |
|---|---|
| Tissue sample | Follow College of American Pathologists guidelines for fixation of tissue samples (Hammond 2010), 8–48 hr, depending on size of specimen |
| Vacuum and controlled temperature | |
| Controlled parafinization protocols | |
| Large samples must be properly handle by a pathologist or well-trained personnel in order to assure formaldehyde penetration and adequate fixation | |
| Cytological samples also useful because alcoholic fixatives excellently preserve DNA | |
| Sample must contain a percentage of tumor cells that is at least 30%. Avoid inflammation, immune infiltrates, and necrosis | |
| Morphological diagnosis should always include the type and grade of the tumors in order to gain insight into genotypic/phenotypic correlations | |
| Decalcification reduces DNA yield and quality. If needed, avoid acid decalcification | |
| Blood sample | EDTA or nucleic acids preserving agent tubes |
| Sample processed immediately after its extraction (ideally in less than 30 min when tubes contain no preservatives) | |
| Tubes treated with heparin must be avoided, since it can inhibit PCR reaction | |
| Centrifugation of the blood sample must be performed at 4 °C using low speed (1000–2000 g for 10 min), to split the hematic pellet from the fractions corresponding to the buffy coat and the plasma | |
| Higher centrifugation speed and time should be avoided to prevent platelet and leucocyte lysis | |
| Fractions obtained after blood centrifugation can be stored at –20 °C during short periods of time and at –80 °C for long terms | |
| Leucocyte fraction, serum, plasma, and whole blood are acceptable for germline DNA (leucocytes preferred) |